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Background: Cystatins are a group of cysteine protease inhibitors responsible for physiological proteolysis regulation
and present in a wide range of organisms. Studies about this class of inhibitors in parasites have contributed to
clarify their roles in important physiological processes, like blood digestion and modulation of host immune
response during blood feeding. Thus, cystatins are a subject of research on the development of new parasite
control methods. Additionally, the characterization of proteins shared by different parasite species represents a
valuable strategy to find potential targets in multi-species control methods. However, cystatin functions in ticks
remain undetermined, especially in Rhipicephalus microplus and Ixodes ovatus, two species that affect livestock
and human health, respectively.
Methods: Here we report the inhibitory profile of two R. microplus (BrBmcys2b and BrBmcys2c) and one I. ovatus
(JpIocys2a) cystatins to commercial cathepsins B, C, and L. The presence of native cystatins in R. microplus tissues
was analyzed using sera against recombinant BrBmcys2b and BrBmcys2c. Also, a peptide from JpIocys2a was
synthesized for rabbit immunization, and this serum was used to analyze the cross antigenicity between R.
microplus and I. ovatus cystatins.
Results: Enzymatic inhibition profile of tick cystatins shows a distinct modulation for cathepsins related to tick
blood digestion and evasion of host immune response. Furthermore, BrBmcys2b was detected in saliva and
different tissues along tick stages, while BrBmcys2c was detected mainly in gut from partially engorged R.
microplus females, demonstrating a distinct pattern of cystatin expression, secretion and traffic between tick
tissues. Moreover, phylogenetic analysis suggests that JpIocys2a belongs to the group of tick gut secreted
cystatins. Finally, cross-antigenicity assays revealed that antibodies against the JpIocys2a peptide recognize
native and recombinant R. microplus cystatins.
Conclusion: The presence of these proteins in different tissues and their ability to differentially inhibit cathepsins
suggest distinct roles for JpIocys2a, BrBmcys2b, and BrBmcys2c in blood digestion, egg and larvae development,
and modulation of host immune response in tick physiology. The cross-antigenicity between native and recombinant
cystatins supports further experiments using JpIocys2a, BrBmcys2b, and BrBmcys2c as vaccine antigens.
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Cystatins are tightly binding inhibitors of cysteine prote-
ases [1]. In parasites, these inhibitors are involved in in-
ternal protective and regulatory biological processes [2]
as well as in the modulation of the host’s defense
responses [3]. Classically, cystatins are divided into three
groups, known as stefin (type 1), cystatin (type 2), and
kininogen (type 3), although in ticks only stefins and
cystatins have been reported [4]. It was only in recent
years that the physiological functions of tick cystatins
[4,5] and their target cysteine cathepsins [6,7] during
tick blood-feeding, digestion and development became
the object of more consistent research. Previous studies
have also demonstrated that tick cystatins modulate host
cathepsins involved in processes like inflammation, anti-
gen processing and presentation, phagocytosis, and cyto-
kine expression [2]. The regulation of these physiological
processes by tick cystatins promotes blood uptake and
survival of parasite while it is attached to the host.
The first tick cystatin biochemically or molecularly
characterized was isolated from Amblyomma ameri-
canum [8]. Back then, the participation of this cystatin
was implicated in host immunomodulation and tick pro-
tection to harmful ingested factors during blood feeding.
In Ixodes scapularis, two cystatins were biochemically
characterized, Sialostatin L and Sialostatin L2 [9,10].
Sialostatin L showed host immune system modulation
and cathepsins L, V, C, X, B, and papain inhibition, while
Sialostatin L2 inhibited cathepsins L, V, S, and C, show-
ing higher expression rate in late feeding. The enzymatic
inhibition profile of Haemaphysalis longicornis cystatins
for papain, cathepsins L, B, H, as well as tick cathepsins
have been characterized in previous research [7,11-14].
Furthermore, it was demonstrated that some of the
cystatins from H. longicornis play a role in innate im-
munity [11] and blood feeding [7,14]. Cystatins from
Ornithodoros moubata were able to inhibit cathepsins B,
L, S, H, and C [15,16], and affect T-cell and dendritic
cells proliferation and cytokine release [16]. Additionally,
it was suggested that one Rhipicephalus appendiculatus
cystatin present in nymph, male and female gut after feed-
ing is involved in blood digestion process [17]. Taken to-
gether, these results indicate that cystatins play widespread
and distinct regulatory roles in different tick species.
Rhipicephalus microplus is one of the most consist-
ently studied cattle tick species, mainly because of the
potentially expressive economic losses it causes in the
livestock industry [18]. However, despite the great inter-
est in understanding the physiology of this tick, few
studies have analyzed R. microplus cystatins. Some R.
microplus cysteine proteases were identified and charac-
terized [19-21], demonstrating the importance of these
enzymes in a variety of physiological processes and para-
site stages. Nevertheless, few R. microplus cystatins andits target cysteine proteases have been characterized, in-
cluding only one type 2 cystatin [5], named Rmcystatin-
3. Rmcystatin-3 is expressed in tick fat body, salivary
glands, and hemocyte, though it inhibits cathepsin L, B,
and BmCl-1, a gut R. microplus cysteine endopeptidase
[19], which suggests its role in tick blood digestion. Con-
sequently, the control of R. microplus cysteine proteases
activities by cystatins remains essentially unknown. In a
previous work [22] we analyzed the sequence properties
and immunogenicity of putative cystatins from R. micro-
plus. These cystatins showed a high degree of homology
among Rhipicephalus spp., differential RNA expression
patterns in tick tissues, as well as cross-reactivity be-
tween them, suggesting the existence of shared epitopes.
The tick Ixodes ovatus geographic prevalence has been
reported in Southeast Asia countries [23,24]. Its main
hosts are humans, and bite cases have been observed in
Tibet, Burma, Nepal, Japan, and China [25]. Borrelia
burgdorferi and Ehrlichia species, which are the causal
agents of Lyme disease and ehrlichiosis, respectively, are
transmitted by ixodid ticks, and I. ovatus was found to
be infected with Borrelia and Ehrlichia species [26-28].
However, no human cases of Lyme disease and ehrlichi-
osis transmitted by I. ovatus have been confirmed to
date [27]. Also, no cystatins were characterized for this
tick species so far.
Tick control is a great challenge in livestock and pub-
lic health management worldwide, and relies on the use
of synthetic acaricides [29]. In spite of that, vaccines
have emerged as an interesting alternative method to
decrease tick populations and the incidence of tick-
borne diseases in the environment [30]. Since hosts in
several regions are exposed to multi-tick infestation, the
development of a single vaccine against multiple species
may be advantageous in control strategies against these
parasites. A number of vaccination experiments showed
the potential use of tick proteins to protect hosts against
more than one tick species, demonstrating the feasibility
of induction of cross-protection [31]. These tick protect-
ive proteins are present in many physiological processes,
like Bm86, a gut protein of unknown function [32];
glutathione-S transferase, an enzyme responsible to de-
toxification of cell xenobiotic compounds [33]; ferritins,
iron-storage proteins [34]; a cement protein named
64TRP [35]; and subolesin, a gene-expression regulator
[36]. In fact, some of these tick antigens, such as Bm86
and its homologues, developed a higher protective host
immune response to different tick species, rather than
the tick species from which the antigen was isolated
[31]. Vaccination trials using cystatins as antigens were
performed against I. scapularis [37] and Ornithodoros
moubata [16] infestations, showing the potential of these
inhibitors to compose a vaccine against ticks. Despite
the importance of cross antigenicity analysis as a
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dates, the potential of cross-protection induced by tick
cystatins has yet to be analyzed.
In order to improve the understanding of the physio-
logical roles of cystatins and the potential of these
inhibitors as antigen in a multi-species vaccine, we char-
acterized the inhibitory profile, tissue expression, and
cross-antigenicity of a new I. ovatus cystatin, JpIocys2a,
and two R. microplus cystatins, BrBmcys2b and
BrBmcys2c. The presence of these proteins in different
tick tissues and their ability to differently inhibit cathep-
sins suggest distinct roles for JpIocys2a, BrBmcys2b, and
BrBmcys2c in blood digestion and modulation of host
immune response in tick physiology. The cross-
antigenicity among cystatins from these two tick species
paves the way for further experiments using JpIocys2a,
BrBmcys2b, and BrBmcys2c as vaccine antigens.
Methods
Animals and ticks
Partially and fully engorged female ticks (Porto Alegre R.
microplus strain) were collected from Hereford (Bos
taurus taurus) cattle for tissue dissection. Partially
engorged R. microplus females weighing between 25 and
60 mg were recovered manually from calves [38]. New
Zealand White rabbits and Hereford cattle were housed
at the Faculdade de Veterinária of the Universidade
Federal do Rio Grande do Sul, Brazil. The experiments
were approved and conducted following the guidelines
of the Ethics Committee on Animal Experimentation of
the same university. I. ovatus adult ticks were collected
by flagging from the lower vegetation in forests in
Hokkaido, Japan, and maintained by experimental in-
festation on hamsters to full engorgement. Hamsters
were maintained in a P3 animal facility at Graduate
School of Veterinary Medicine, Hokkaido University in
accordance with the Institutional Animal Care and Use
Committee guidelines.
Cloning of cystatin ORF sequences
For cloning of the JpIocys2a sequence, primers 5′-GACTA
GTCGCCAGCACGATGGCT-3′ (forward) and 5′-TGTCA
TTTAACATGCGGCTGACGTC-3′ (reverse) were de-
signed based on TIGR nucleotide database (TC51659)
from I. scapularis gene sequence with high similarity to
cystatins. One ORF was amplified by RT-PCR from I.
ovatus ovary RNA and cloned in pGEM-T vector
(Promega). For cloning the DNA sequence encoding
the mature JpIocys2a protein in the expression vector,
the plasmid pGEM-T-JpIocys2a was amplified using the
primers 5′-TTTTTGGATCCGGGTCGGCGAGCAGG
TC-3′ (forward) and 5′-AAAAAGAATTCCTAGACATTA
TTAGGAGCTTCGCAGTGGTAG-3′ (reverse). The PCR
product was hydrolyzed with Bam HI and Eco RI(Invitrogen) restriction enzymes and separated by elec-
trophoresis on 0.8% agarose gel. The 396-bp fragment
was excised, purified using the Geneclean II Kit (Qbio-
gene), and ligated into plasmid pGEX-4 T-1 (GE
Healthcare) downstream the Glutathione S-transferase
(GST) gene, which codifies the fusion protein. The
plasmid pGEX-4T-1-JpIocys2a was transformed into
Escherichia coli XL1BLUE strain. Transformed cells were
plated and cultivated in LB agar containing ampicillin and
chloramphenicol (50 μg/mL). The plasmid was purified
and the cloned product was confirmed by sequencing.
The BrBmcys2b and BrBmcys2c nucleotide sequences
were previously cloned [22]. In short, cystatin-coding re-
gions were amplified by PCR from R. microplus salivary
gland cDNA and cloned into plasmid pET-5a (Novagen).
In silico analyses
JpIocys2a DNA sequence analysis, amino acid predic-
tions, and sequences alignment were conducted using
the BioEdit version 7.2.5 software [39]. The cystatin anti-
genic index was calculated using the Jameson–Wolf
algorithm in the software LASERGENE, version 7.0.0, to
predict antigenic determinants by combining existing
methods for protein structural predictions [40]. For
phylogenetic analysis, an unrooted neighbor-joining
phylogenetic tree was created using the MEGA software,
version 5 [41]. Bootstrap support was assessed using
1000 replicates. The GenBank accession numbers for
cystatins used in analysis were: R. microplus BrBmcys2b
[GenBank: KC816580], R. microplus BrBmcys2c [Gen-
Bank: KC816581], R. microplus Rmcystatin-3 [GenBank:
AIX97454]; I. ovatus JpIocys2a [GenBank: KP253747]; I.
scapularis sialostatin 1 [GenBank: AF483724], I. scapu-
laris sialostatin 2 [GenBank: DQ066048]; H. longicornis
Hlcyst-2 [GenBank: DQ364159], H. longicornis Hlcyst-3
[GenBank: EU426545].
Peptide synthesis
To raise antibodies against conserved and exposed re-
gions among tick cystatins, a peptide with 14 amino
acids from the JpIocys2a amino acid sequence was syn-
thesized (STQpep). Antigenic analysis of cystatins and
percentage of identity among JpIocys2a, BrBmcys2a,
BrBmcys2b, Brbmcys2c, and other tick cystatins were
used to select the peptide. Peptides were kindly provided
by Maria Aparecida Juliano, Department of Biophysics,
Federal University of São Paulo (UNIFESP), SP, Brazil.
An automated bench-top simultaneous multiple solid-
phase peptide synthesizer (PSSM 8 system, Shimadzu)
was used for the solid-phase synthesis of the peptides by
the Fmoc-procedure. Final peptides were deprotected in
trifluoracetic acid and purified by semipreparative HPLC
using an Econosil C-18 column. Analytical HPLC was
performed using a binary HPLC system from Shimadzu
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an Ultrasphere C-18 column. The HPLC column elutes
were monitored by their absorbance at 220 nm. The mo-
lecular weight and purity of synthesized peptides were
checked by MALDI-TOF mass spectrometry (Bruker
Daltons) or electron spray LC/MS-2010 (Shimadzu) [42,43].
Expression and purification of recombinant cystatins
E. coli C41 (DE3), C43 (DE3) and RIL strains were trans-
formed with plasmids containing the BrBmcys2b,
BrBmcys2c, and JpIocys2a sequences, respectively. The
recombinant proteins BrBmcys2b and BrBmcys2c were
expressed in SOB medium with 0.4 mM isopropyl-β-D-
thiogalactopyrano (IPTG) for 16 h at 25°C. rGST-
JpIocys2a protein was expressed in LB medium with
0.1 mM IPTG for 24 h at 37°C. Cells were further
harvested by centrifugation at 10,000 × g for 10 min at
4°C. rBrBmcys2b and rBrBmcys2c were resuspended in
phosphate buffer containing 100 mM of imidazole (lysis
buffer) and rGST-JpIocys2a in PBS. For cell lysis, the
suspension was sonicated five times for 30 s at 40 MHz
on ice (Sonics or Qsonica, respectively). The soluble and
insoluble fractions were separated by centrifugation at
10,000 × g for 10 min at 4°C (Hitachi).
The soluble fractions containing the rBrBmcys2b and
rBrBmcys2c were purified by nickel-chelating Sepharose
chromatography (GE Healthcare). Briefly, the soluble
fractions were filtered in 0.45-μm filters (Whatman) and
then applied into the columns previously equilibrated
with phosphate lysis buffer. Proteins of interest were
eluted with phosphate buffer containing 150 mM of
imidazole at room temperature. Eluted fractions were
purified using centrifugal filter devices (Centricon
YM10 - 50,000 MW cut-off, Millipore), lyophilized and
dialyzed against PBS. The soluble fractions containing
the rGST-JpIocys2a was purified by Glutathione Sepharose
4B (Amersham Bioscience) and eluted with 50 mM Tris–
HCl buffer and 10 mM glutathione, in pH 8.0. Purified
rGST-JpIocys2a was dialyzed in cleavage buffer (NaCl
140 mM, KCl 2.7 mM, Na2HPO4 10 mM, KH2PO4
1.8 mM, pH 7.3) and cleaved by Thrombin (0.01u/μg;
Sigma). rGST fusion protein was bound by Glutathione
Sepharose 4B, and pure rJpIocys2a was recovered in theTable 1 Cystatins dissociation constants (KIs) for different pro
Enzyme Family Enzyme
concentration
Cathepsin B 1 Cysteine protease 0.500 μM
Cathepsin C 1 Cysteine protease 0.160 μM
Cathepsin L 2 Cysteine protease 0.043 μM
Cathepsin G 2 Serine protease 0.100 μM
n.i., not inhibited in the presence of 0.5 μM recombinant cystatin.
1Bovine cathepsin.
2Human cathepsin.supernatant. Protein concentrations were determined
using the BCA Protein Assay kit (Thermo Scientific) fol-
lowing the manufacturer’s instructions.
Enzymatic assays
Remaining enzymatic activity and apparent dissociation
constants (KIs) were estimated using different cathepsins
(Sigma) to determine the inhibitory profile of rBrBmcys2b,
rBrBmcys2c, and rJpIocys2a. Enzymes were preincubated
with recombinant cystatins at different concentrations
ranging from 10 to 500 nM in the corresponding assay
buffer for 15 min, and protease-specific substrates (Sigma)
were added to estimate residual enzyme activity. Enzymes
concentrations are presented in Table 1. Assay buffer and
enzymes were used as follows: 100 mM sodium acetate,
pH 5.5, 100 mM NaCl, 1 mM EDTA, and 0.005%
TritonX-100 for bovine cathepsin C and human cathepsin
L; 100 mM sodium acetate, pH 5.5, 60 mM NaCl, 1 mM
EDTA for bovine cathepsin B; 100 mM HEPES, pH 7.5,
1 mM EDTA for human cathepsin G. For KIs determin-
ation, substrates were used as follows: Z-Phe-Arg-MCA
(0.012-0.1 mM) for cathepsin L; Z-Arg-Arg-pNA (0.012-
1.0 mM) for cathepsin B; Gly-Phe-pNA (0.6-2.25 mM) for
cathepsin C; N-Succinyl-Ala-Ala-Pro-Phe-pNA (0.67 mM)
for cathepsin G. Chromogenic (405 nm of absorption)
and fluorescence intensity (370 and 460 nm for emis-
sion and excitation, respectively) assays were monitored
in a microplate spectrophotometer (Spectramax Micro-
plate Reader, Molecular Devices Corporation). Data
were fit for appropriate tight-binding inhibitors using a
nonlinear regression analysis equation (Morrison, 1969)
performed using GraphPad Prism version 5.00 for
Windows (GraphPad Software).
Tick tissues extraction
Salivary glands, ovary, gut, fat body and larvae were dis-
rupted and homogenized using a mortar and pestle in
an ice bath with 10 mM phosphate buffer, pH 7.2. The
homogenate was centrifuged at 16,000 × g for 15 min at
4°C to remove the insoluble material. Next, the soluble
supernatant fraction was collected. The protein extracts
were prepared according to the method previously de-
scribed [44]. Tick hemolymph was collected as follows:teases
Ki (nM)
rBrBmcys2b rBrBmcys2c rJpIocys2a
0.82 ± 0.35 n.i. 154.70 ± 106.71
26.65 ± 6.75 0.45 ± 0.12 >1 μM
2.48 ± 1.00 28.45 ± 2.34 4.39 ± 1.76
n.i n.i. n.i.
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70%, fixed to Petri dishes and kept at 4°C; the cuticle
was slit with a razor blade and the exuding hemolymph
recovered and stored at −20°C. Saliva was collected by
pilocarpine injection as previously described [45].
Immunization of hamsters and rabbits
Two hamsters were subcutaneously inoculated with
50 μg of rBrBmcys2c or PBS. Immunizations consisted
of four doses at 14-day intervals with the recombinant
proteins emulsified in Freund’s incomplete adjuvant.
Two rabbits were subcutaneously immunized four times
at 14-day intervals with 625 μg of STQpep conjugated
with carrier protein keyhole limpet hemocyanin (KLH;
Sigma) or 200 μg of GST from H. longicornis [46] both
emulsified in Marcol-Moltanide (Exxon Mobil Corpor-
ation) adjuvant. Hamsters and rabbit blood were
collected 14 days after the last booster, and sera were
separated by centrifuging samples at 10,000 × g for
5 min at 4°C. Serum aliquots were preserved at −20°C
upon use. Mice sera used in serological analysis were
produced in a previous study [22].
SDS-PAGE and Western blotting
The production of recombinant cystatins and the pres-
ence of native cystatin in tissues were analyzed by SDS–
PAGE [47] and Western blot [48]. For Western blot
analyses, recombinant cystatins (1 μg protein/lane),
saliva (20 μg protein/lane), hemolymph (60 μg protein/
lane) and tissue extracts (150 μg protein/lane) were
resolved in 14% gel for SDS-PAGE, followed by transfer-
ence to nitrocellulose membranes. The membranes were
blocked with 5% non-fat dry milk in PBS and further
incubated with mice, hamster or rabbit sera diluted to
1:50. Additionally, for rBmcys2b, rBmcys2c, and rJpIo-
cys2a detection, anti-histidine tag or anti-GST-Hl
antibodies (1:2,000) were used. After primarily sera incu-
bations, anti-IgG species specific alkaline phosphataseFigure 1 JpIocys2a nucleotide and predicted amino acid sequences
residues are in gray and the conserved cystatin motifs PI (G), P II (QxVxG)(mouse and rabbit sera) and peroxidase (hamster
serum) conjugates (1:5,000) were used as secondary
antibodies. Alkaline phosphatase revelations were
performed with NBT (nitro blue tetrazolium) and
BCIP (5-bromo-4-chloro-3-indolyl phosphate, Sigma)
in PBS. Peroxidase revelations were performed with
DAB (3,3′-diaminobenzidine tetrahydrochloride), H2O2
and CoCl2 in PBS.
Results
JpIocys2a identification and sequence analyses
JpIocys2a nucleotide sequence showed an ORF of
423 bp, and the deduced amino acid sequence contained
a signal peptide with cleavage site between amino acid
residues 18 and 19 and four cysteine residues with a the-
oretical molecular weight of 15.6 kDa (Figure 1). The G
residue on N-terminal, the motif QxVxG and the PW at
the C-terminal are characteristic of family 2 cystatins,
and are also conserved in JpIocys2a. The SND inhibitory
domain, which inhibits legumain/asparaginyl endopepti-
dases found in human cystatin C, is absent in JpIocys2a,
like other tick cystatins [4].
In silico antigenicity of cystatins and peptide selection
The alignment of JpIocys2a with R. microplus cystatins
showed conserved regions among the predicted amino
acid sequences (Figure 2). The amino acid sequence
STQVEGREYYDTVL from JpIocys2a (STQpep) was
selected for peptide synthesis in accordance with the highest
identity and antigenic region among all cystatins analyzed.
Production of recombinant cystatins
Soluble recombinant BrBmcys2b, BrBmcys2c, and GST-
JpIocys2a were expressed in E. coli and purified by affin-
ity chromatography. rGST-JpIocys2a was cleaved from
GST-tag by thrombin and the purified rJpIocys2a was
recovered (Figure 3). SDS-PAGE showed that the conju-
gated rGST-JpIocys2a protein weight was about 42 kDa. The predicted signal peptide (SignalP) is underlined. Cysteine
, and P III (PW) are boxed.
Figure 2 Conserved and antigenic tick cystatin regions for JpIocys2a peptide selection. Antigenic index plots for tick cystatins were
predicted using the Jameson–Wolf algorithm. Graphic increased positivity shows predictive antigenic sites. Alignment shows conserved
regions between JpIocys2a and R. microplus cystatins. Black boxes indicate conserved and antigenic amino acid region for each sequence.
Asterisk indicate the selected region for peptide synthesis.
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the weight of cystatins was approximately 12 kDa. These
data are in accordance with in silico molecular weights
estimation. rBrBmcys2b and rBrBmcys2c were recog-
nized by anti-histidine tag antibodies, and rGST-
JpIocys2a was recognized by anti-GST-Hl in Western
blot assay. The purified recombinant cystatins were sub-
sequently used in inhibitory and immunization assays.
rJpIocys2a, rBrBmcys2b, and rBrBmcys2c inhibitory
profile
Inhibitory assays were performed to characterize the speci-
ficity of rJpIocys2a, rBrBmcys2b, and rBrBmcys2c for target
enzymes (Figure 4 and Table 1). rJpIocys2a, rBrBmcys2b,
and rBrBmcys2c modulated the activity of mammalcathepsins B, C, and L at distinct patterns. rJpIocys2a and
rBrBmcys2b inhibited all cysteine cathepsins, showing
higher affinity for cathepsin L and B, respectively (Table 1).
In contrast, rBrBmcys2c did not inhibit cathepsin B, show-
ing higher affinity for cathepsin C. Also, rJpIocys2a,
rBrBmcys2b, and rBrBmcys2c inhibited these peptidases
with apparent inhibition constants between 0.45 and 154.7
nM. The exception was rJpIocys2a, which shows Ki higher
than1 μM for cathepsin C. Cathepsin G, a serine protease,
was not inhibited by these recombinant cystatins.
Recognition of native and recombinant cystatins by
hyperimmune sera
Sera against STQpep, rBrBmcys2b and rBrBmcys2c were
used to determine the presence of cystatins in R.
Figure 3 SDS-PAGE and Western blot of rJpIocys2a, rBrBmcys2b and rBrBmcys2c production. Western blot: purified rGST-JpIocys2a probed
with anti-GST-Hl primary antibody and rabbit anti-IgG secondary antibody conjugate with alkaline phosphatase; purified rBrBmcys2b and rBrBmcys2c
probed with anti-histidine tag primary antibody conjugate with alkaline phosphatase. Alkaline phosphatase revelations were performed with NBT and
BCIP. SDS-PAGE: Recombinant cystatins resolved by 14% SDS-PAGE were stained with Coomassie blue G-250; purified rGST-JpIocys2a before and after
thrombin cleavage (rGST and JpIocys2a); purified rJpIocys2a, rBrBmcys2b and rBrBmcys2c. MW: molecular weight.
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tween peptide, native, and recombinant cystatins
(Figure 5). Native cystatins present in saliva, larvae,
ovary, gut, salivary glands, and fat body (apparent
molecular mass of 12 kDa) were differentially recog-
nized by these sera. Native cystatins were recognized
by anti-rBrBmcys2b in all tissues (Figure 5A), whereas
anti-rBrBmcys2c sera recognized cystatins in gut from
partially engorged females and in ovary, salivary glands
and fat body from fully engorged females (Figure 5B).
rBrBmcys2b and native cystatins from partially and
fully engorged female salivary glands were recognized
by anti-STQpep sera (Figure 5C). The hosts sera inocu-
lated with PBS did not recognize native cystatins in
these tissues (data not shown). Furthermore, anti-
rBrBmcys2b serum detected cystatin in hemolymph
(Figure 5A), unlike anti-rBrBmcys2c and negative con-
trols sera. Since these sera were raised against STQpep
and recombinant cystatins, this recognition shows theFigure 4 Activity inhibition assay of cathepsins B, C, and L by rJpIocy
incubated with Z-Arg-Arg-pNA (0.125 mM), Gly-Phe-pNA (1.8 mM), or Z-Phe-Ar
of rJpIocys2a, rBrBmcys2b, and rBrBmcys2c. The abscissa shows inhibitors con
enzymatic activity. Incubation of cathepsins B, C, and L without rJpIocys2a, rBrcross-antigenicity between native and peptide/recom-
binant cystatins.Phylogenetic analysis
A neighbor-joining tree constructed with cystatin
amino acid sequences from Ixodidae ticks is shown in
Figure 6. We selected sequences of cystatins that have
inhibitory profile and tissue localization that have been
characterized. In the tree constructed, BrBmcys2b and
BrBmcys2c grouped with other cystatins present in sal-
iva/salivary glands and gut, respectively, showing tissue
localization conservation between cystatin from the
two branches of the tree. JpIocys2a grouped with the
branch of cystatins expressed mainly in gut, suggesting
the importance of this cystatin in tick blood digestion.
All these cystatin are cathepsin L inhibitors, whereas
cystatins that inhibit cathepsin B and C are present in
the two branches.s2a, rBrBmcys2b, and rBrBmcys2c. Cathepsins B, C, and L were
g-MCA (0.02 mM), respectively, in the presence of different concentrations
centration (nM, log10); the ordinate shows percentage of remaining
Bmcys2b, and rBrBmcys2c represents 100% of enzyme activity.
Figure 5 Cross-immunogenicity between native and recombinant
tick cystatins. By Western blot, R. microplus and I. ovatus recombinant
cystatins or R. microplus tissue extracts were analyzed using sera (1:50)
against: A) rBrBmcys2b; B) rBrBmcys2c C) STQpep. SG, salivary glands;
OV, ovary; FB, fatty body, S, saliva; H, hemolymph; L, larva; SGp, salivary
glands from partially engorged female; SGt, salivary glands from fully
engorged female; C2b, rBrBmcys2b; C2c, rBrBmcys2c; CIo, rJpIocys2a.
MW: molecular weight. Anti-IgG alkaline phosphatase rabbit sera and
peroxidase hamster sera conjugates were used as secondary antibodies.
Alkaline phosphatase revelations were performed with NBT and BCIP.
Peroxidase revelations were performed with DAB, H2O2 and CoCl2.
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The function of cystatins in parasite physiological pro-
cesses is a subject of increasing interest among many re-
search groups [3,49]. In ticks, however, only in recent
years did cystatin roles begin to be elucidated [4]. The
main goals of these works were the characterization of
cathepsin targets, tissue localization and immune systemFigure 6 Phylogenetic analysis of tick cystatins. R. microplus BrBmcys2b
microplus Rmcystatin-3 [GenBank: AIX97454]; I. ovatus JpIocys2a [GenBank: K
sialostatin 2 [GenBank: DQ066048]; H. longicornis Hlcyst-2 [GenBank: DQ364
1,000 simulations are shown at the branches.modulation by tick cystatins. To date, no I. ovatus and
only two R. microplus cystatin were biochemically char-
acterized [5,50]. In the present work, we characterized
the inhibition profile of one I. ovatus and two R. micro-
plus cystatins. To uncover the inhibitory profile of these
cystatins, we selected three cysteine proteases involved in
host hemoglobin proteolytic degradation cascade by ticks
[51-53]. In enzymatic inhibition assays, rBrBmcys2b inhib-
ited cathepsins B, C, and L activities, and was detected in
all tissues and secretions analyzed, suggesting the broad
enzymatic regulation by this inhibitor in R. microplus
physiology. Among the tissues from partially engorged
females analyzed, BrBmcys2c was detected only in gut,
suggesting the role of BrBmcys2c in blood metabolism. A
potential target for this cystatin could be BmCL1, VTDCE
and/or RmLCE, cathepsins from R. microplus that were
detected in tick gut during feeding stages [19,20,54]. The
pattern of native BrBmcys2b and BrBmcys2c expression
corroborates previous qPCR results, which showed a
higher mRNA transcripts expression in gut, as compared
to other tick tissues [22]. The presence of BrBmcys2b in
tissue that showed no transcription for this cystatin gene
maybe the result of cystatin synthesis in gut, and its subse-
quent exportation to other tissues, similarly to other tick
proteins [21,55,56]. The presence in hemolymph of
BrBmcys2b, but not BrBmcys2c, supports this hypothesis.
JpIocys2a inhibited cathepsins B, C and L at different
levels. Cathepsin L and B were highly inhibited, when
compared to C inhibition. The phylogenetic tree analysis
show that JpIocys2a grouped together with gut cystatins,
indicating that JpIocys2a could be secreted in I. ovatus gut
lumen. In Ixodes ricinus blood digestion, cathepsins B and
L hydrolyze hemoglobin secondary large fragments,
whereas cathepsin C degrades it down to small fragments
[51]. Therefore, JpIocys2a may have major importance
during modulation of initial hemoglobin degradation in
blood digestion by ticks.[GenBank: KC816580], R. microplus BrBmcys2c [GenBank: KC816581], R.
P253747]; I. scapularis sialostatin 1 [GenBank: AF483724], I. scapularis
159], H. longicornis Hlcyst-3 [GenBank: EU426545]. Bootstrap values of
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the role of tick cystatins in the modulation of host im-
mune system components responsible for anti-parasite
infestation [10,16,57]. Similarly to Sialostatin L2 [37],
rBrBmcys2b and rBrBmcys2c were not recognized by
sera of tick-infested hosts (data not shown), indicating
that the R. microplus cystatins are not immunogenic for
bovines when inoculated through tick bite. The presence
of BrBmcys2b in R. microplus saliva as well as its ability
to inhibit cathepsin L suggests the participation of this
cystatin in mechanisms to avoid host immune system.
Cathepsin L is involved in mammal immune system
process by MHC class II-presentation pathway regula-
tion [58], as well as extracellular matrix breakdown dur-
ing inflammation [59]. Cathepsin L secreted by
macrophages inside tick feeding cavity would destroy
host tissue elasticity, which is required for the effective
parasite attachment [10]. Inhibition of cathepsin L by se-
creted tick cystatins would help tick feeding, whereas
the absence of these compounds would result in inflam-
mation and parasite rejection due to the host’s immune
response. This outcome was observed in tick cystatin
knock-down and vaccination experiments [8,10,16,37].
Consequently, host cathepsin L inhibition would result
in a weaker immune response against tick infestation.
The presence of BrBmcys2b in partially and fully
engorged female ovary indicated that this cystatin is
important during egg development. In ovary, a vitellin
degrading cysteine endopeptidase (VTDCE) that plays a
crucial physiological role in egg maturation through
vitellin mobilization [21,54] is a potential enzyme target
for BrBmcys2b.
In silico and in vitro comparative cross-antigenicity
analyses of tick proteins, as CRTs [60], or GSTs [61],
showed that, despite their high amino acid sequence
conservation between homologues, these proteins dis-
play different immunodominant epitopes. Furthermore,
antibodies against CRT and GST from H. longicornis
were able to recognize native and recombinant forms of
R. microplus homologous proteins [60,61]. Moreover,
when GST-Hl was used in a vaccination trial against R.
microplus infestation in cattle, the number of engorged
females decreased by around 50% [61]. To select immu-
nodominant epitopes to explore the potential of cystatin
in an anti-tick vaccine, a peptide from JpIocys2a was
synthesized based on their antigenicity and similarity
with R. microplus cystatins, and used for rabbit
immunization. This approach seems to be interesting,
because the immune response generated against
designed peptide could be directed to immunodominant
protective epitopes in native proteins. Synthetic peptide
based vaccines have been studied as a strategy against
malaria [62], hepatitis C [63,64], foot-and-mouth disease
[65], human papilloma virus [66] and Toxoplasma gondii[67]. Vaccination experiments using synthetic peptide
from R. microplus Bm86 and Plasmodium falciparum
also induced antibodies that recognized proteins from
which the amino acid sequence had originated [68]. Fur-
thermore, the peptides selected from R. microplus Bm86
developed a protection in cattle ranging between 36%
and 81% [68]. In this work, STQ-pep immunization gen-
erating antibodies that recognize native and recombinant
R. microplus cystatins showed cross-reactivity in the
selected peptide region. The results reveal that the pep-
tide construct is immunogenic, allowing to recognize
rJpIocys2a by anti-STQpep antibodies. The cross-
reaction of STQ-pep with native cystatins from R.
microplus salivary glands and rBrBmcys2b paves the
way for further works testing this peptide for a cross-
antigenic vaccine.
Conclusions
This work showed the differential presence of cystatins
in R. microplus tick tissues, and demonstrates that
cathepsins B, C, and L are modulated by JpIocys2a,
BrBmcys2b, and BrBmcys2c to different degrees. These
results suggest distinct tick physiological roles for these
cystatins: BrBmcys2b acts during blood meal processing,
egg and larva development, and in host immune system
modulation; and BrBmcys2c and JpIocys2a act mainly
during blood meal processing. Future anti-hemostatic
and immunomodulatory experiments will better clarify
the importance of JpIocys2a, BrBmcys2b, and BrBmcys2c
in tick physiology.
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